Effectiveness and safety of anakinra in gout patients with stage 4–5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study
ConclusionAnakinra may be a safe therapeutic option for gout patients with advanced CKD. Further randomized controlled studies are required to confirm our results.
Source: Joint Bone Spine - Category: Orthopaedics Source Type: research
More News: Academia | Arthritis | Chronic Kidney Disease | Gout | Kidney Transplant | Kidney Transplantation | Rheumatology | Study | Transplant Surgery | Transplants | Urology & Nephrology